NYSE:AZN

European Stocks Rally on Pharma Shakeups, Tech Surge – What’s Next?

Market Overview On Monday, Europe’s stock markets built on last week’s Fed-inspired optimism. Investors cheered a mix of corporate news and the prospect of more US rate cuts. Britain’s FTSE 100 climbed roughly 0.5%, putting it near record highs, and

29 September 2025

Wall Street Braces for Shutdown: Stocks Rally as Fed Cuts Loom – Tech & Defense in Focus

Sources: Reuters, CNBC, Bloomberg, company filings reuters.com globenewswire.com reuters.com reuters.com reuters.com reuters.com reuters.com.

29 September 2025

Defense Industry · Economic Policy · Federal Reserve · NYSE:AZN · NYSE:GSK · NYSE:JEF · NYSE:STLA · Stock Market · Technology

Tariffs Fail to Derail European Stock Rally as Markets Bounce Back

Market Recap: Relief Rally Ends a Volatile Week German DAX stock index graph displayed at the Frankfurt Stock Exchange. European markets rebounded off three-week lows heading into the weekend (Sept. 24, 2025) reuters.com reuters.com European stocks staged a broad relief

27 September 2025

European Economy · Financial News · Market Analysis · NYSE:AZN · NYSE:GSK · NYSE:IHG · Stock Market · Trade Tariffs

Wall Street Rebounds: PCE In‑Line, Tariff Shock, and Fed‑Cut Bets — What It All Means (Sept. 26, 2025)

Key facts (today) The U.S. stock market today — what moved prices 1) The data that mattered: PCE & spendingMarkets exhaled as the Fed’s preferred inflation gauge arrived exactly as expected: headline PCE +0.3% m/m (2.7% y/y), core +0.2% m/m (2.9% y/y). Treasury yields drifted

26 September 2025

Economic Data · Federal Reserve · Investment Analysis · NASDAQ:GFS · NASDAQ:INTC · NASDAQ:VKTX · NYSE:AZN · NYSE:LLY · NYSE:PCAR · Stock Market · Tariffs

Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Key Facts German DAX index graph at the Frankfurt Stock Exchange, reflecting volatile mid-week trading reuters.com. Pan-European Overview: From Slump to Rebound European equities seesawed over the two days, buffeted by transatlantic trade tensions and shifting rate expectations. On Thursday

26 September 2025

Economic News · European Markets · Interest Rates · NYSE:AZN · NYSE:NVO · NYSE:NVS · Stock Market · Tariffs

AI Pathology Breakthrough: Roche’s Lung Cancer Diagnostic Makes FDA History

In April 2025, Roche’s Ventana TROP2 (EPR20043) RxDx test became the first AI-powered diagnostic to receive FDA Breakthrough Device Designation. The device pairs an immunohistochemistry stain for TROP2 with a digital pathology AI algorithm that runs in Roche’s Navify system

17 July 2025

AI in Healthcare · FDA Approvals · Medical Diagnostics · NYSE:AZN · NYSE:RHHBY · Oncology · Technological Innovation

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Late 2024, the first FDA-approved CRISPR-based therapy exagamglogene autotemcel (Casgevy) reached patients, with Vertex reporting $2 million in revenue from this sickle-cell gene-editing therapy in Q3 2024. Prime Medicine’s PM359 autologous CRISPR prime-edited cell therapy for chronic granulomatous disease began

27 June 2025

2025 Trends · Biotechnology · Forecast · Health Tech · Medical Innovation · NASDAQ:ABEO · NASDAQ:ITCI · NASDAQ:PRME · NASDAQ:RARE · NASDAQ:RGLS · NASDAQ:SWTX · NASDAQ:VRTX · NASDAQ:WVE · NYSE:AZN · NYSE:CTLT · NYSE:JNJ · NYSE:NVO · NYSE:NVS

NYSE:AZN News 27 June 2025 - 29 September 2025